These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 19056743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.
    Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447
    [Abstract] [Full Text] [Related]

  • 3. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M, Verstreken S, Geelen P, Penicka M, De Bruyne B, Bartunek J.
    Eur Heart J; 2007 Sep 01; 28(17):2134-41. PubMed ID: 17504802
    [Abstract] [Full Text] [Related]

  • 4. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.
    Am J Cardiol; 2006 Jul 15; 98(2):230-5. PubMed ID: 16828599
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
    Sitges M, Vidal B, Delgado V, Mont L, Garcia-Alvarez A, Tolosana JM, Castel A, Berruezo A, Azqueta M, Pare C, Brugada J.
    Am J Cardiol; 2009 Aug 01; 104(3):383-8. PubMed ID: 19616672
    [Abstract] [Full Text] [Related]

  • 8. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.
    Fung JW, Zhang Q, Yip GW, Chan JY, Chan HC, Yu CM.
    J Cardiovasc Electrophysiol; 2006 Dec 01; 17(12):1288-92. PubMed ID: 16987381
    [Abstract] [Full Text] [Related]

  • 9. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H, Behrens S, Eisermann C.
    Europace; 2008 Dec 01; 10(12):1375-80. PubMed ID: 18776196
    [Abstract] [Full Text] [Related]

  • 10. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group.
    J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy.
    Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, Thomas JD, Schalij MJ, Piérard LA, Bax JJ.
    Eur Heart J; 2008 Mar 10; 29(6):757-65. PubMed ID: 18305084
    [Abstract] [Full Text] [Related]

  • 16. Are the extent, location, and score of segmental wall motion abnormalities related to cardiac resynchronization therapy response?
    Shen X, Aronow WS, Nair CK, Holmberg MJ, Hee T, Maciejewski S, Esterbrooks DJ.
    Echocardiography; 2009 Nov 10; 26(10):1136-45. PubMed ID: 19725853
    [Abstract] [Full Text] [Related]

  • 17. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.
    Riedlbauchová L, Brunken R, Jaber WA, Popová L, Patel D, Lánská V, Civello K, Cummings J, Burkhardt JD, Saliba W, Martin D, Schweikert R, Wilkoff BL, Grimm R, Natale A.
    J Cardiovasc Electrophysiol; 2009 Jan 10; 20(1):50-7. PubMed ID: 18803571
    [Abstract] [Full Text] [Related]

  • 18. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?
    Henneman MM, Chen J, Dibbets-Schneider P, Stokkel MP, Bleeker GB, Ypenburg C, van der Wall EE, Schalij MJ, Garcia EV, Bax JJ.
    J Nucl Med; 2007 Jul 10; 48(7):1104-11. PubMed ID: 17574987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG.
    J Card Fail; 2008 Oct 10; 14(8):670-5. PubMed ID: 18926439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.